(9-330) Assessing Adherence to Rifaximin Drug Use Criteria in Patients with Hepatic Encephalopathy in a Community Hospital Setting

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Shelby Gaudet

Primary Author(s)